Original Source(s)
Related Content
Roswell Park Launches Exclusive Phase 1 Clinical Trial of ‘Armored’ CAR T-Cell Therapy for Ovarian Cancer
Roswell Park Comprehensive Cancer Center is currently recruiting for a phase 1 clinical trial of the new therapy (NCT07489287), called GB-5267, which was co-developed by Roswell Park and the therapeutics company Generate:Biomedicines.
June 24, 2026
-
3 min
Smartphones Spot Ocular Malignancies
Could a smartphone-based AI system bring ocular oncology screening directly into the patient’s home?
July 2, 2026
-
3 min
Mass Spec Roundup: Signals Recovered
This week’s stories span amino-metabolite imaging, site-specific HDX-MS, large-scale motif annotation, and proteomics missing-value recovery
July 15, 2026
-
7 min